Ontology highlight
ABSTRACT:
SUBMITTER: Dunn K
PROVIDER: S-EPMC9044782 | biostudies-literature | 2022 Jan-Dec
REPOSITORIES: biostudies-literature
Dunn Keith K Baugh Bryan B Bejou Nika N Luo Donghan D Campbell Jennifer J Seyedkazemi Sareh S Anderson David D
Journal of the International Association of Providers of AIDS Care 20220101
Gastrointestinal intolerance has been associated with ritonavir-boosted protease inhibitors. This post hoc analysis evaluated gastrointestinal adverse events of interest (AEOIs; diarrhea, nausea, abdominal discomfort, flatulence [MedDRAv21]) through Wk96 among patients enrolled in the phase 3 AMBER (treatment-naïve) and EMERALD (virologically suppressed) studies of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) 800/150/200/10 mg. 362 and 763 patients initiated D/C/F/TAF in ...[more]